The FDA Center for Veterinary Medicine is responsible for ensuring
that animal drugs and medicated feeds are safe and effective
for their intended uses and that food from treated animals is
safe for human consumption. Before a new animal drug can be
marketed in the U.S., it must be approved by the FDA on the
basis of quality, safety, and efficacy. When the drug is for
use in food-producing animals, not only must the safety to the
animal be demonstrated, but also the safety of food products
derived from the treated animals that are intended for human
consumption.
Once approved products are on the market, the Center monitors
the use of the products through surveillance and compliance
programs.
One of CVM's highest priorities is assuring the safety of the
food supply through elimination of violative residues in meat
and milk. And, because of that work and the cooperative efforts
of all FDA employees, the United States can boast the safest
food supply in the world.
The responsibilities of the Center for Veterinary Medicine
have a direct effect on the safety of the human food supply
and on the safety to animals of veterinary products. CVM works
to educate consumers as well as the regulated industry; evaluates
data on proposed veterinary products carefully before permitting
them to be marketed; discovers violative marketed products through
surveillance programs and initiates legal action, if necessary,
to bring violators into compliance with the law; and conducts
research to support Center activities.
Whether developing and disseminating information, approving
animal drug products for marketing, monitoring marketed animal
drug products, or conducting research, CVM is committed to the
important goal of protecting animal and human health throughout
the United States -- working together to keep the country's
food supply the safest in the world.
The management staff is primarily responsible for overseeing
the day-to-day operation of the Center. They oversee the setting
and implementation of its goals and direction. They also manage
such functions as budget, personnel matters, training for employees,
data processing, document maintenance, and the dissemination
of information regarding the Center's mission to other Centers
within FDA, other government agencies, and the public.
The pre-marketing staff determine whether or not a drug should
be approved for marketing. Pre-marketing reviewers study data
submitted by drug sponsors to determine if submitted data are
adequate to support a drug's approval for marketing.
The post-marketing staff monitor marketed animal drugs, food
additives, and devices to assure continuing safety and effectiveness.
They also process legal cases brought against violators by the
Center.
The research staff in CVM conduct studies to support both pre-
and post-marketing activities by providing information to aid
CVM scientists in the review and decision-making processes.
A closer look at each of the four groups (and the Director's
Office) will show how they interact to accomplish FDA's mission.
Updated August 10, 1999 at 3:10 PM ET
|